# Boston Scientific to acquire Axonics for $3.7B

Boston Scientific announced a definitive agreement to acquire Axonics, a medical technology company focused on devices for urinary and bowel dysfunction, for $71 per share, representing an equity value of approximately $3.7 billion.

- Type: Acquisition
- Announced: 2024-01-08
- Where: United States
- Value: $3.70B
- Status: announced
- Products: sacral neuromodulation systems, urethral bulking system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [Axonics](https://endata.com/companies/74823.md) (target)

## Sources

- [news.bostonscientific.com](https://news.bostonscientific.com/2024-01-08-Boston-Scientific-Announces-Agreement-to-Acquire-Axonics,-Inc), 2024-01-08: "Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Axonics, Inc., a publicly traded medical technology company primarily focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.